Australian psychologists' attitudes towards psychedelic‐assisted therapy and training following a world‐first drug down‐scheduling
Drug and Alcohol Review November 5, 2024 Jordan J Negrine, Cheneal Puljević, Jason Ferris et al. 8 citations
Australian psychologists generally hold positive attitudes toward psychedelic-assisted therapy (PAT) following the 2023 regulatory changes that permitted psilocybin and MDMA in clinical services. Most view PAT as promising for chronic mental health conditions like depression, but express concerns about limited evidence on efficacy, potential adverse experiences, and the complexity of individualized treatment protocols. Many psychologists lack detailed knowledge about the interventions. The findings emphasize the need for comprehensive education and training programs, including exposure to psychedelic experiences and credible higher education institutions, to ensure competent administration of PAT.